← Evidence map

ArticleHuman vaccines & immunotherapeutics2022

COVID vaccine efficacy against the B.1.351 ("South African") variant-The urgent need to lay the groundwork for possible future challenge studies.

Nir Eyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2021

2022

this papercites it

COVID vaccine efficacy against the B.1.351 ("South African") variant-The urgent need to lay the groundwork for possible future challenge studies. | OpenQuestion